VESIQUE
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

VESIQUE Trademark

Serial Number: 90696589 • Registration: 6988499

VESIQUE is a trademark filed by Jiangsu Yahong Meditech Incorporated Company on May 7, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Jiangsu Yahong Meditech Incorporated Company (2 trademarks)

Innovation Base II, Yaocheng Road No.1
Taizhou, Jiangsu 225316 , CN

Entity Type: 03

Trademark Details

Filing Date

May 7, 2021

Registration Date

February 28, 2023

Published for Opposition

June 14, 2022

Goods & Services

Medicines for human purposes for the treatment of viral, metabolic, endocrine, genitourinary, oncological, hormonal related diseases and disorders, and for preventing, inhibiting and treating mold, mildew, bacteria; Chemico-pharmaceutical preparations for the treatment of viral, metabolic, endocrine, genitourinary, oncological, hormonal related diseases and disorders, and for preventing, inhibiting and treating mold, mildew, bacteria; Chemical preparations for pharmaceutical purposes for the treatment of viral, metabolic, endocrine, genitourinary, oncological, hormonal related diseases and disorders, and for preventing, inhibiting and treating mold, mildew, bacteria; Chemical preparations for medical purposes for the treatment of viral, metabolic, endocrine, genitourinary, oncological, hormonal related diseases and disorders, and for preventing, inhibiting and treating mold, mildew, bacteria; Biological preparations for medical purposes for the treatment of viral, metabolic, endocrine, genitourinary, oncological, hormonal related diseases and disorders, and for preventing, inhibiting and treating mold, mildew, bacteria; Drugs for medical purposes for the treatment of viral, metabolic, endocrine, genitourinary, oncological, hormonal related diseases and disorders, and for preventing, inhibiting and treating mold, mildew, bacteria; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, genitourinary, oncological, hormonal related diseases and disorders, and for preventing, inhibiting and treating mold, mildew, bacteria; Troche for the treatment of viral, metabolic, endocrine, genitourinary, oncological, hormonal related diseases and disorders, and for preventing, inhibiting and treating mold, mildew, bacteria; Medical preparations which can be injected for the treatment of viral, metabolic, endocrine, genitourinary, oncological, hormonal related diseases and disorders, and for preventing, inhibiting and treating mold, mildew, bacteria

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 6, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Nov 6, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 6, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 6, 2024 REAP
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 28, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 28, 2023 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Jan 23, 2023 DP1B
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 23, 2023 AITU
NOTICE OF ALLOWANCE CANCELLED
Dec 8, 2022 IUCN
TEAS DELETE 1(B) BASIS RECEIVED
Dec 8, 2022 D1BR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 6, 2022 NOAM
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Oct 23, 2022 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Jul 12, 2022 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 14, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jun 14, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 25, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 8, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
May 8, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 8, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
May 8, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 8, 2022 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 6, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 5, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 5, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 18, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jan 18, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jan 18, 2022 CNRT
ASSIGNED TO EXAMINER
Jan 12, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 9, 2021 NWOS
NEW APPLICATION ENTERED
May 11, 2021 NWAP